-
1
-
-
3042826338
-
Advances in the management of Chlamydia pneumoniae infections
-
Hammerschlag MR. Advances in the management of Chlamydia pneumoniae infections. Expert Rev Anti Infect Ther 2003; 1: 493-503.
-
(2003)
Expert Rev Anti Infect Ther
, vol.1
, pp. 493-503
-
-
Hammerschlag, M.R.1
-
2
-
-
0034807046
-
In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae
-
Miyashita N, Fukano H, Niki Y et al. In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae. J Antimicrob Chemother 2001; 48: 403-5.
-
(2001)
J Antimicrob Chemother
, vol.48
, pp. 403-405
-
-
Miyashita, N.1
Fukano, H.2
Niki, Y.3
-
3
-
-
1242307776
-
Tissue kinetics of telithromycin, the first ketolide antibacterial
-
Muller-Serieys C, Andrews J, Vacheron F et al. Tissue kinetics of telithromycin, the first ketolide antibacterial. J Antimicrob Chemother 2004; 53: 149-57.
-
(2004)
J Antimicrob Chemother
, vol.53
, pp. 149-157
-
-
Muller-Serieys, C.1
Andrews, J.2
Vacheron, F.3
-
4
-
-
3042554709
-
Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/ 6J mice
-
Törmäkangas L, Saario E, Bem David D et al. Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/ 6J mice. J Antimicrob Chemother 2004; 53: 1101-4.
-
(2004)
J Antimicrob Chemother
, vol.53
, pp. 1101-1104
-
-
Törmäkangas, L.1
Saario, E.2
Bem David, D.3
-
5
-
-
0041525439
-
Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia
-
Carbon C, Moola S, Velancsics I et al. Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia. Clin Microbiol Infect 2003; 9: 691-703.
-
(2003)
Clin Microbiol Infect
, vol.9
, pp. 691-703
-
-
Carbon, C.1
Moola, S.2
Velancsics, I.3
-
6
-
-
0023472821
-
High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes
-
Koga H. High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes. Antimicrob Agents Chemother 1987; 31: 1904-8.
-
(1987)
Antimicrob Agents Chemother
, vol.31
, pp. 1904-1908
-
-
Koga, H.1
-
7
-
-
0034526844
-
Evaluation of the activity of antimicrobial agents against Legionella pneumophila multiplying in a human monocytic cell line, THP-1, and an alveolar epithelial cell line, A549
-
Kunishima H, Takemura H, Yamamoto H et al. Evaluation of the activity of antimicrobial agents against Legionella pneumophila multiplying in a human monocytic cell line, THP-1, and an alveolar epithelial cell line, A549. J Infect Chemother 2000; 6: 206-10.
-
(2000)
J Infect Chemother
, vol.6
, pp. 206-210
-
-
Kunishima, H.1
Takemura, H.2
Yamamoto, H.3
-
8
-
-
19544366269
-
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin
-
Bosnar M, Kelnerić Z, Munić V et al. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother 2005; 49: 2372-7.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 2372-2377
-
-
Bosnar, M.1
Kelnerić, Z.2
Munić, V.3
-
9
-
-
0032841480
-
The new ketolide HMR 3647 accumulates in the azurophil granules of human polymorphonuclear cells
-
Miossec-Bartoli C, Pilatre L, Peyron P et al. The new ketolide HMR 3647 accumulates in the azurophil granules of human polymorphonuclear cells. Antimicrob Agents Chemother 1999; 43: 2457-62.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 2457-2462
-
-
Miossec-Bartoli, C.1
Pilatre, L.2
Peyron, P.3
-
10
-
-
0002707963
-
Investigation of the uptake of HMR 3647, HMR 3004 and roxithromycin by myelomonocytic cell lines
-
San Francisco, CA, Abstract 1929. American Society for Microbiology, Washington, DC, USA
-
Vazifeh D, Labro MT. Investigation of the uptake of HMR 3647, HMR 3004 and roxithromycin by myelomonocytic cell lines. In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 1929. American Society for Microbiology, Washington, DC, USA.
-
(1999)
Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Vazifeh, D.1
Labro, M.T.2
|